The biotech’s phase 3 delivered the hoped-for second biomarker hit, reporting an 82% decline in serum creatine kinase after 12 months. BridgeBio’s base case and upside targets for the muscle damage ...
PAP is a rare lung condition that can be difficult to diagnose because it may mimic many other more common lung diseases,” ...
TipRanks on MSN
United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension
United Therapeutics Corp. (($UTHR)) announced an update on their ongoing clinical study. United Therapeutics Corp. is conducting a study titled ...
All primary and secondary interim analysis endpoints in FORTIFY Phase 3 study successfully achieved with well-tolerated safety profile ...
TipRanks on MSN
Pfizer’s New Study on PF-07868489: A Potential Game-Changer for Pulmonary Arterial Hypertension?
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 2 open-label extension study titled ‘A ...
9hon MSN
Innovative diagnostic method brings fast and affordable pneumonia detection to low-resource settings
Pneumonia remains one of the leading causes of death in low- and middle-income countries, where access to advanced medical ...
Objectives To describe the characteristics of COVID-19 among elite Japanese athletes and their return-to-play (RTP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback